Navigation Links
New gene variants associated with glucose, insulin levels, some with diabetes risk
Date:1/17/2010

A major international study with leadership from Massachusetts General Hospital (MGH) researchers has identified 10 new gene variants associated with blood sugar or insulin levels. Two of these novel variants and three that earlier studies associated with glucose levels were also found to increase the risk of type 2 diabetes. Along with a related study from members of the same research consortium, associating additional genetic variants with the metabolic response to a sugary meal, the report will appear in Nature Genetics and has been released online.

"Only four gene variants had previously been associated with glucose metabolism, and just one of them was known to affect type 2 diabetes. With more genes identified, we can see patterns emerge," says Jose Florez, MD, PhD, of the MGH Diabetes Unit and the Center for Human Genetic Research, co-lead author of the report. "Finding these new pathways can help us better undertand how glucose is regulated, distinguish between normal and pathological glucose variations and develop potential new therapies for type 2 diabetes."

Both studies were conducted by the Meta-Analyses of Glucose and Insulin-related Traits Consortium (MAGIC), a collaboration among researchers from centers in the U.S., Canada, Europe and Australia that analyzed gene samples from 54 previous studies involving more than 122,000 individuals of European descent. The study co-led by MGH scientists along with colleagues from Boston University, University of Cambridge, University of Oxford and the University of Michigan began by analyzing about 2.5 million gene variations (called SNPs) from 21 genome-wide searches for variants associated with glucose and insulin regulation in more than 46,000 nondiabetic participants. The 25 most promising SNPs from the first phase were then tested in more than 76,000 nondiabetic participants in 33 other studies, leading to new associations of nine SNPs with fasting glucose levels and one with fasting insulin and with a measure of insulin resistance.

Analysis of genetic data from additional studies involving both diabetic and nondiabetic participants found that five glucose-level-associated variants two of those newly identified and three discovered in previous studies were also shown to raise type 2 diabetes risk. Most of the diabetes-associated variants appear to act through their impact on insulin secretion by the pancreatic beta cells and not by insulin resistance, which suggests, the authors note, that environmental factors such as diet, lifestyle and obesity may play a larger role in insulin resistance than in insulin secretion.

"The fact that not all genes involved with raising glucose levels increase diabetes risk tells us that it's not the mere fact of raising glucose that's important but rather how glucose is raised. It's one thing to increase glucose slightly within the normal range and quite another to affect a pathway that eventually leads to progressive glucose elevation, beta-cell failure or insulin resistance in other words type 2 diabetes, " says Florez, who is an assistant professor of Medicine at Harvard Medical School. "We've still only identified about 10 percent of the genetic contribution to glucose levels in nondiabetic individuals, so we need to investigate the impact of other, possibly more complex or rare forms of gene variation, along with the role of gene-environment interactions, in causing type 2 diabetes. Performing similar studies in non-European populations will also be essential."


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related biology news :

1. Identification of genetic variants affecting age at menopause could help improve fertility treatment
2. Common gene variants influence risk factor for sudden cardiac death
3. Common gene variants increase risk of hypertension, may lead to new therapies
4. International study identifies gene variants associated with early heart attack
5. Mayo: Variants in gene on X chromosome associated with increased susceptibility to Alzheimers
6. New gene variants present opportunities in nutrigenomics
7. Study identifies genetic variants giving rise to differences in metabolism
8. Interaction between gene variants may alter brain function in schizophrenia
9. Genetic variants of USF1 are associated with the increased risk for cardiovascular disease
10. New genetic variants associated with lipid levels, risk for coronary artery disease
11. Scientists associate 6 new genetic variants with heart disease risk factor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/16/2017)... -- CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog ... Used combined in one project, multi-biometric solutions provide ... ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD), and ... have partnered to deliver exclusive content to ReachMD learners. , The partnership, ...
(Date:3/29/2017)... year,s petition to the White House signed by 120,000 ... generate awareness on the importance of new organic medicines and nutritional ... place. ... this month Health Advance (OTC PINK: HADV ), ... announced its endeavors on this generally recognized as safe ...
(Date:3/29/2017)... , March 29, 2017  Applied BioMath ... mechanistic modeling to drug research and development, ... with Zymeworks Inc. for quantitative systems pharmacology ... intended for the treatment of cancer. ... previously for GLP toxicology studies and first-in-human ...
(Date:3/29/2017)... Canaan, CT (PRWEB) , ... March 29, 2017 , ... ... antibiotics and hormones in the world’s food supply through enhancement of the gut microbiota, ... the round included Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC ...
Breaking Biology Technology: